Distinct chromatin structures at the monoamine oxidase-A promoter correlate with allele-specific expression in SH-SY5Y cells by Manca, M et al.
Manca, M and Pessoa, V and Myers, P and Pickles, A and Hill, J and Sharp,
H and Murgatroyd, C and Bubb, VJ and Quinn, JP (2018)Distinct chro-
matin structures at the monoamine oxidase-A promoter correlate with allele-
specific expression in SH-SY5Y cells. Genes, Brain and Behavior. ISSN
1601-183X
Downloaded from: http://e-space.mmu.ac.uk/620718/
Version: Published Version
Publisher: Wiley
DOI: https://doi.org/10.1111/gbb.12483
Usage rights: Creative Commons: Attribution 4.0
Please cite the published version
https://e-space.mmu.ac.uk
OR I G I N A L A R T I C L E
Distinct chromatin structures at the monoamine oxidase-A
promoter correlate with allele-specific expression in SH-SY5Y
cells
M. Manca1,2 | V. Pessoa1,2 | P. Myers1 | A. Pickles3 | J. Hill4 | H. Sharp2 |
C. Murgatroyd5 | V. J. Bubb1 | J. P. Quinn1
1Department of Molecular and Clinical
Pharmacology, Institute of Translational
Medicine, University of Liverpool,
Liverpool, UK
2Institute of Psychology, Health and Society,
University of Liverpool, Liverpool, UK
3King's College London, MRC Social Genetic
and Developmental Psychiatry Research
Centre, Institute of Psychiatry, London, UK
4School for Psychology and Clinical Language
Sciences, University of Reading, Reading, UK
5School of Healthcare Science, Manchester
Metropolitan University, Manchester, UK
Correspondence
J. P. Quinn, Department of Molecular and
Clinical Pharmacology, University of Liverpool,
Liverpool L69 3BX, UK.
Email: jquinn@liverpool.ac.uk
Funding information
Medical Research Council, Grant/Award
Number: G0400577; University of Liverpool;
Wellcome Trust
Monoamine oxidase-A (MAOA) metabolises monoamines and is implicated in the pathophysiol-
ogy of psychiatric disorders. A polymorphic repetitive DNA domain, termed the uVNTR
(upstream variable number tandem repeat), located at the promoter of the MAOA gene is a risk
factor for many of these disorders. MAOA is on the X chromosome suggesting gender could
play a role in regulation. We analysed MAOA regulation in the human female cell line, SH-SY5Y,
which is polymorphic for the uVNTR. This heterozygosity allowed us to correlate allele-specific
gene expression with allele-specific transcription factor binding and epigenetic marks for
MAOA. Gene regulation was analysed under basal conditions and in response to the mood sta-
biliser sodium valproate. Both alleles were transcriptionally active under basal growth condi-
tions; however, the alleles showed distinct transcription factor binding and epigenetic marks at
their respective promoters. Exposure of the cells to sodium valproate resulted in differential
allelic expression which correlated with allele-specific changes in distinct transcription factor
binding and epigenetic marks at the region encompassing the uVNTR. Biochemically our model
for MAOA promoter function has implications for gender differences in gene × environment
responses in which the uVNTR has been implicated as a genetic risk.
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1 | INTRODUCTION
Monoamine oxidase-A (MAOA) metabolises monoamines and as such
it is implicated in the pathophysiology of stress-related illnesses,
including major depressive disorder, addiction and violent behav-
iour.1,2 A major mediator of MAOA expression is a polymorphic repet-
itive domain termed the uVNTR (upstream variable number tandem
repeat) located in what was considered the promoter of the major
transcript of the MAOA gene.3 The uVNTR is a 30 base pair repeat
element that can be present in 2, 3, 3.5, 4 or 5 copies. The 2, 3 and
5 repeat variants are defined as low expression (MAOA-L) alleles
whilst the 3.5 and 4 repeat uVNTR are considered high expression
variants (MAOA-H).4 These low and high expression alleles can
represent either a risk or a protective factor depending on the disor-
der studied.4–11 It is thought that the uVNTR acts as a classical tran-
scriptional regulator in the promoter of the MAOA gene and that the
distinct variants support differential MAOA expression in a tissue-
specific and stimulus inducible manner. This gene and the uVNTR
polymorphism are amongst the most often cited example of a geno-
type by environment interaction (G × E) in which an individual's geno-
type moderates the effect of environmental experience to alter
mental health outcomes.6 Simplistically, the function of the uVNTR is
modified by the complement of active transcription factors in the cell,
altered in response to the environment, that are then able to recog-
nise and bind to the uVNTR thus allowing the domain to act as a tran-
scriptional regulator. However, bioinformatic data now indicates that
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there are at least 2 transcriptional start sites (TSSs) for the MAOA
gene, a further isoform is produced from a more 50 TSS. This newly
described TSS now places the uVNTR in the 50UTR (50 untranslated
region) of the MAOA gene, Figure 1, adding to the complexity of tran-
scriptional regulation at this locus.
MAOA is located on the X chromosome and therefore genetic
associations of the uVNTR with neuropsychiatric disorders in the male
are simplified by having only one allele. However, associations of the
uVNTR in females are complicated by not knowing the contribution of
each allele to MAOA expression and the potential for one allele to
exhibit X inactivation. This problem is made more difficult as the
MAOA locus has been proposed as one of the loci that can escape X
inactivation.12–14 To address the mechanisms which might underpin
allele expression in the female we took advantage of the human
neuroblastoma-derived SH-SY5Y cell line which has a female karyo-
type and is heterozygous for the uVNTR. This heterozygosity of the
uVNTR allows us to distinguish allelic-specific differences in epigenetic
marks and transcription factor binding to the DNA encompassing the
uVNTR in addition to identification of allele-specific expression directed
by the most 50 TSS. In this communication we were able to show that
both alleles, at least in the population of SH-SY5Y cells, can support
mRNA expression. This phenomenon was also observed in cDNA pre-
pared from saliva from females who were heterozygous for the uVNTR.
Using chromatin immunoprecipitation (ChIP) analysis in SH-SY5Y cells
we show that each allele can support distinct transcription factor,
histone-binding and methylation patterns. The pattern of factor binding
and methylation over each allele was also correlated with a switch in
allele-specific gene expression in response to sodium valproate in SH-
SY5Y cells.
2 | MATERIALS AND METHODS
2.1 | Cell culture
The human neuroblastoma cell line SH-SY5Y (ATCC/CRL-2266) which
is near diploid (47 chromosomes)15 was cultured in a 1:1 mix
of Dulbecco's EMEM (Sigma, Dorset, UK) and Ham's F12 (Sigma)
media supplemented with 10% (vol/vol) foetal bovine serum, 2 mM L-
glutamine (Sigma), 1 mM sodium pyruvate (Sigma) and penicillin
100 units/mL/streptomycin 0.1 mg/mL (Sigma), at 37C in a humidi-
fied 5% CO2 atmosphere. Cells were cultured to 70% to 80% conflu-
ence with culture media being replaced every other day. The stimulus
2 μM sodium valproate (Sigma) was added directly to the existing
media for 1 hour.
2.2 | Total RNA preparation and cDNA synthesis
Total RNA was extracted from SH-SY5Y cells using Trizol reagent
(Invitrogen, Paisley, UK) and quantified using a NanoDrop 8000 Spec-
trophotometer (Thermo Fisher Scientific, Wilmington, DE, USA).
Three micrograms of total RNA was reverse-transcribed to single-
stranded cDNA using GoScript Reverse Transcription System
(Promega, Southampton, UK) and random primers according to the
manufacturers' instructions.
2.3 | Polymerase chain reaction
Amplification of the MAOA uVNTR was performed using the primers
previously described,3 forward 50-GAACGGACGCTCCATTCGGA-30
and reverse 50-ACAGCCTGACCGTGGAGAAG-30. Reactions con-
tained 10 ng of DNA template, 5 pmol of each primer (Eurofins, Ebers-
berg, Germany), 1× GoTaq flexi buffer, 1 mM MgCl2 and 0.625 U of
GoTaq DNA polymerase (Promega), 0.1 mM of each dNTP and 1 M
betaine (Sigma). Cycling conditions were 2 minutes at 95C initial
denaturation, followed by 35 cycles of 20 seconds at 95C, 20 sec-
onds at 61C and 30 seconds at 72C and final elongation for
5 minutes at 72C. Polymerase chain reaction (PCR) products were
analysed using 1.5% agarose gels stained with ethidium bromide solu-
tion (Sigma) and visualised using a ultraviolet (UV) transilluminator.
2.4 | Chromatin immunoprecipitation
Human SH-SY5Y cells were grown to 80% confluence in a T175 flask
and treated for 1 hour under the following conditions, basal
FIGURE 1 Graphic representation of MAOA promoter region based on The University of California Santa Cruz (UCSC) genome web browser,
Hg38. From top to bottom: reference gene sequence; previous version of UCSC genome using Hg19; upstream tandem repeat: uVNTR; CpG
islands; Encyclopedia of DNA Elements (ENCODE) transcription factor data (data version: ENCODE Mar 2012 Freeze) indicating those factors
shown to bind to this region in specific cell lines, in short the darker the line the more confidence in the association; ENCODE data for H3K27Ac
mark (often found near active regulatory elements) on 7 cell lines
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(untreated), 2 μM sodium valproate and vehicle alone. Samples were
processed using the methods described by Murgatroyd et al.16 The
immunoprecipitations were performed using the following antibodies:
anti-Histone H3 (Abcam, Cambridge, UK), anti-Nucleolin (Abcam),
anti-hnRNP K (Abcam), anti-CCHC-Type Zinc Finger Nucleic Acid
Binding Protein gene (CNBP) (Abcam), anti-RNA pol II CTD phospho
Ser5 (Active Motif, Carlsbad, California), anti-Sp1 and anti-CCCTC-
Binding Factor gene (CTCF) (Millipore, Nottingham, UK). PCR analysis
of the immunoprecipitated samples was performed using primers tar-
geting the MAOA uVNTR as described above.
2.5 | Methylation analysis
SH-SY5Y genomic DNA (gDNA) was isolated and purified using
QIAmp DNA Mini Kit (Qiagen, Manchester, UK). Genomic DNA was
then fragmented by sonication using the Bioruptor Plus set at
10 cycles of 30-second pulses followed by 30-second pauses on
high power. Three hundred nanograms of fragmented gDNA was
incubated with CpG MethylQuest (Millipore) beads (Glutathione-S-
Transferase - Methyl Binding Domain (GST-MBD) fusion protein)
and binding buffer at room temperature for 1 hour with rotation.
The supernatant was removed and stored for subsequent analysis,
the beads were washed and the methylated DNA was eluted. Both
methylated DNA (elutant) and unmethylated DNA (supernatant)
were analysed by PCR of the MAOA uVNTR as previously
described.
2.6 | Saliva sample collection and RNA extraction
The saliva, was collected in the Oragene RNA container (DNA Geno-
tek, ON, Canada) until the volume of saliva reached the indicated level
marked on the collection tube, following the protocol outlined in the
manufacturers' instructions. Five samples were obtained from children
whose families were participating in the Wirral Child Health and
Development Study (WCHADS). The WCHADS is funded by the
Medical Research Council and run in partnership with National Health
Service (NHS) Wirral, NHS Western Cheshire and Wirral University
Teaching Hospital NHS Foundation Trust. It has received full ethical
approval from Cheshire Local and North West 5 Research Ethics
Committees (ref: 05/Q1506/107). Total RNA was extracted using Tri-
zol reagent (Invitrogen) from the saliva samples. One microgram of
total RNA was reverse-transcribed to single-stranded cDNA using
GoScript Reverse Transcription System (Promega) and random
primers, according to the manufacturers' instructions.
3 | RESULTS
3.1 | Human MAOA gene promoter architecture
The uVNTR was originally described as being 1.2 kb upstream of the
TSS of the MAOA gene,3 however, later bioinformatic analysis from
data in Hg19 and Hg38 of the human genome using ENCODE data on
the USCS genome browser (http://genome.ucsc.edu)17 showed an
additional TSS which is upstream of the uVNTR. Thus, the uVNTR can
also be included in the 50UTR of this MAOA isoform using the most
50TSS, Figure 1. The ENCODE data shows those transcription factors
determined by ChIP assay in a variety of cell lines to bind to this
MAOA uVNTR/promoter region including CTCF and SP1 that bind
Cytosine-Guanine (CG)-rich sequences in addition to RNA polymerase
II (POLR2A). The sequence of this region of the MAOA promoter is
rich in CpG given the 2 CpG islands overlapping both TSS.
3.2 | Allelic-specific regulation of MAOA expression
We used the human neuroblastoma cell line SH-SY5Y to address
MAOA expression. SH-SY5Y is a well-characterised cell line which
was originally isolated from a 4-year-old female. Genotyping of this
cell line showed that it was heterozygous for the uVNTR with alleles
containing either 3 or 4 copies of the repeat element. This allowed
identification of allelic-specific expression of the MAOA isoform
which initiated from the most 50 TSS because mRNA initiating here
included the uVNTR in the 50UTR. Under basal growth conditions we
were able to detect MAOA mRNA corresponding to expression from
both alleles using the uVNTR length as the distinguishing feature,
Figure 2A. This PCR is the standard protocol extensively used and val-
idated for addressing uVNTR variation at the level of DNA.9,11 A vari-
ety of other PCRs across MAOA exons and control genes were
utilised to confirm the fragment was not generated by contaminating
genomic DNA in the cDNA (data not shown). Confirmation of the
sequence of the MAOA fragments identified from the PCR was con-
firmed by sequence analysis of fragments after cloning into a reporter
gene for future studies (data not shown). Similarly, analysis of cDNA
prepared from saliva from females heterozygous for the uVNTR
showed that in vivo expression from both alleles could be observed in
the same individual, Figure 2B.
Attempts to use qPCR to measure allele-specific expression over
heterozygous VNTRs were problematic perhaps due to preferential
amplification of a specific allele in early rounds of PCR and consistent,
FIGURE 2 Expression of 2 MAOA isoforms: 1.5% agarose gel of MAOA uVNTR PCR amplification. Amplicon size 324 bp for 3R uVNTR, 354 bp
for 4R uVNTR. A, SH-SY5Y cell line cDNA: lanes from left to right: 100 bp ladder marker; basal condition; vehicle control: H2O 1 hour; sodium
valproate treatment 1 hour; PCR negative control. B, Human female cDNA samples: lanes from left to right: 100 bp ladder marker; 2×
homozygous 3R/3R uVNTR; 3× heterozygous 3R/4R uVNTR
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reproducible data was difficult to obtain. However, using the hetero-
zygous cell line SH-SY5Y we could utilise the size variation of the dis-
tinct uVNTRs to compare intensity between and within experiments
for the same primer set; this showed that in SH-SY5Y cells in response
to exposure to sodium valproate, a mood stabiliser, a switch in the
levels of MAOA allelic expression was observed. Specifically, the ratio
of L- to S-allele expression was reproducibly reversed, Figure 2A. This
switch in relative levels of expression cannot be explained by PCR
allele preference. As the MAOA gene is on the X chromosome the
expression of both alleles in the SH-SY5Y cells might require this
region to escape X inactivation as has been previously reported for
the MAOA locus.12–14 Alternatively, the expression of both alleles
could be construed as a mosaic effect of random silencing of one
allele in any particular cell and thus the population would appear to
express both alleles.
To explore the allelic expression further we analysed by ChIP
transcriptional and epigenetic variation at the uVNTR domain in SH-
SY5Y cells in response to sodium valproate. The methylation status of
both alleles was addressed by their ability to bind Methyl-CpG-binding
domain (MBD). This showed, by addressing the ratio of each uVNTR
allele, a clear specificity in that the 4 copy uVNTR promoter was pre-
dominantly methylated under basal growth conditions whereas the
3 copy uVNTR promoter was hypomethylated, Figure 3. The methyla-
tion pattern was altered when the cells were exposed to sodium
valproate. Specifically, variation was mostly clearly observed in the
methylated fractions, in which methylation could now be easily
observed over the 3 copy allele; the ratio of methylated 4 copy allele
to 3 copy allele was quite distinct from basal conditions, Figure 3. We
therefore explored binding of RNA polymerase II and the transcription
factors CTCF and SP1 identified from ENCODE data as binding to the
uVNTR, Figure 1, to gain insight into potential transcriptional mecha-
nisms operating at this locus.
RNA polymerase II was showed to be present on both alleles
under basal conditions, consistent with expression from both alleles,
Figure 4A, lane 4. This was in stark contrast to Histone 3 (His3) under
basal conditions, Figure 4B, lane 4 (His3), which was found predomi-
nantly on the shorter, 3 copy repeat, uVNTR allele. Similar to the
observations obtained for His3, under basal growth conditions, or
exposure to H20 as the vehicle control, CTCF and SP1 transcription
factor binding was predominantly observed on the short, 3 copy
uVNTR allele, Figure 4C, top and middle panel, lanes 7 and 8. Upon
exposure to sodium valproate, Figure 4C, bottom panel, lanes 8, there
was a significant increase for SP1 binding to the short 3 copy allele
which is correlated with the switch to increased expression of the lon-
ger 50TSS containing the 3 copy uVNTR in the 50UTR observed in
Figure 2A.
The distinct promoter architecture is suggestive of a distinct/spe-
cific mechanism to regulate each MAOA-allelic promoter based in part
on uVNTR repeat copy number. In the literature, CTCF and SP1 both
bind double stranded DNA but recognise the same sequences as the
single stranded DNA-binding proteins, hnRNPK and CNBP.18,19 These
single stranded DNA-binding proteins were also bound predominantly
to the short 3 copy allele under basal conditions, Figure 4C top and
centre panel, lanes 4 and 5, but in response to valproate they now also
bound the 4 copy allele, Figure 4C, bottom panel, lanes 4 and 5. This
was in stark contrast to SP1 binding which was dramatically increased
only on the 3 copy allele. In contrast the binding of CTCF was not sig-
nificantly changed in response to valproate with any change in distri-
bution, it remained bound predominantly to the 3 copy allele. CTCF
function on transcription is varied, ranging from repression to tran-
scriptional pausing and transactivation which in part is dependent on
interacting partners, one of which is nucleolin which can mediate
intra- and interchromosomal interactions.20 Analysis of nucleolin by
ChIP indicated it binding weakly to the 3 copy allele under basal con-
ditions with a vast increase in binding after exposure of the cells to
valproate, Figure 4C, bottom panel, lane 6. It should be noted that
nucleolin can also interact with SP1 and both these factors were dra-
matically increased in their binding to the short allele after exposure
to valproate.
4 | DISCUSSION
The MAOA uVNTR is one of the best characterised G × E interac-
tions in the literature and the accepted hypothesis is that the differ-
ent repeat copy numbers of the uVNTR direct the differential
expression of MAOA in response to the environment. This is a rela-
tively straightforward explanation for the male gender which has
only one allele for MAOA. However, the situation is more complex
in females for several reasons including (1) gene dosage, (2) the
potential for MAOA to escape X-inactivation and (3) heterozygosity
of the uVNTR whose genotype might direct distinct MAOA gene
expression patterns.
We investigated the molecular mechanisms underlying MAOA
expression in the human neuroblastoma cell line SH-SY5Y which is
both female and heterozygous for the uVNTR. This heterozygosity of
the uVNTR was crucial for our study to allow us to correlate mRNA
expression from each MAOA allele with transcription factor binding
and epigenetic marks over the uVNTR. Our data indicated that both
alleles of the MAOA gene were active in SH-SY5Y cells, albeit by very
distinct molecular mechanisms based on the binding of proteins and
methylation marks over this region. Most noticeably although both
FIGURE 3 Methylation at the MAOA promoter. PCR amplification of
sheared gDNA post CpG MethylQuest treatment. Amplicon size
324 bp for 3R uVNTR, 354 bp for 4R uVNTR. Lane 1, 100 bp ladder
marker; lanes 2 to 4 PCR of uVNTR under basal condition; vehicle
control: H2O; sodium valproate PCR of unmethylated DNA (not
bound to methyl domain-binding protein; CpG MethylQuest protein).
Lanes 5 to 7, PCR of uVNTR under basal condition; vehicle control:
H2O; sodium valproate treatment of methylated DNA (bound to
methyl domain-binding protein; CpG MethylQuest protein)
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alleles had very different chromatin structures (methylation and tran-
scription factor interactions), when ChIP was performed for an active
RNA polymerase, binding was observed at both alleles which was con-
sistent with the cDNA studies showing that both alleles were active
despite the distinct chromatin architecture, Figure 4A. The methyla-
tion of one allele which apparently did not repress MAOA expression,
Figure 3, would be consistent with recent work on X chromosome
gene expression patterns which indicated that methylation did not
necessarily correlate with gene repression but rather functioned as a
parameter affecting a region's ability to escape X inactivation.13 To
further investigate the regulation of MAOA gene expression by the
uVNTR we analysed binding for 5 transcription factors: CTCF, SP1,
hnRNP K, CNBP and nucleolin. Our data provided evidence that these
proteins recognised the proximal MAOA promoter encompassing the
uVNTR and more importantly a distinct pattern of binding was
observed over each individual allele which was modulated both by
genotype of the uVNTR and exposure of the cells to sodium valpro-
ate, Figure 4C. This data was consistent with a role for gender in regu-
lation of MAOA expression via epigenetic mechanisms, for example,
the gender-specific changes of methylation in a longitudinal study of
twins21 and hypomethylation in the pathogenesis of panic disorder
particularly in female patients.22
Our model could in part explain the differences in uVNTR geno-
type association for specific mental health issues when male and
females are compared, such examples include: MAOA uVNTR moder-
ating the relationship between childhood maltreatment and dysthymia
only in females,23 gender differences including pronounced effects on
Attention-deficit hyperactivity disorder (ADHD) and anxiety in
females whereas the opposite is true for autism, bipolar disorder and
aggressive behaviour in males.4,24 Indeed many studies of MAOA G ×
E report only on males due to compounding affects including female
heterozygosity for the uVNTR.6,8,11 This regulation could be further
complicated in that the MAOA gene is one of the approximately 15%
of X chromosome genes estimated to escape X inactivation.12–14
However, there is still much debate about X inactivation in vivo and
there may be no reason why X-inactivation of the second allele in
females itself is not dependent on G × E interactions. Consistent with
this, the gene termed a master regulator of X chromosome inactiva-
tion, X Inactive Specific Transcript gene (XIST), is over expressed in
females with major affective disorders.25 Thus, it is likely that both
sex-based and disorder-based differences exist and our study high-
lights one potential mechanism to explain such differences.
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